NGNE

Conviction 62HealthcareScan · Thu, Sep 24, 2026

Neurogene Inc. (NGNE) closed at $31.25 (+1.03%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 37, RS Rating 91, -27.1% from its 52-week high, +55.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

NGNE$31.25+1.03%

ResistanceSupportVol 14Insider sell

Vol MA14 423.47K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Neurogene Inc.PHARMACEUTICAL PREPARATIONSwww.neurogene.com ↗

Price31.25

Change+1.03%

Gap+2.13%

Rel volume3.19×

Avg volume348.72K

Avg $ vol11.85M

SMA 2035.36

SMA 5035.85

SMA 20027.02

Price vs 50-12.83%

Price vs 200+15.68%

MA stackmixed

50/200 cross—

Supertrenddown · 37.76

RSI (14)37

MACD hist-0.59

MACD cross—

Stoch %K / %D11 / 15

ADX (14)16

+DI / −DI17 / 28

RSI divergence—

MACD divergence—

ATR %7.11%

ADR %6.13%

52w high42.84

52w low16.37

From 52w high-27.05%

Above 52w low+90.90%

New 52w highNo

SqueezeOff

Bollinger width28.18%

%B0.09

Donchian pos11.23%

Donchian high40.42

Donchian low30.09

AVWAP (52w high)35.76

vs AVWAP high-12.60%

AVWAP (52w low)30.34

vs AVWAP low+3.01%

OBV trendFlat

Chaikin MF (20)-0.21

Today vs 20d3.19×

Avg vol (14d)423.47K

Avg vol (20d)348.72K

Avg $ vol (20d)11.85M

Market cap625.36M

RS Rating91 / 99

RS 3m (vs SPY)-1.73%

RS 6m (vs SPY)+25.03%

RS line new highNo

Trend template5/8

Technical rank60.2

1 week-3.58%

1 month-23.48%

3 months+2.76%

6 months+41.85%

1 year+85.46%

YTD+55.01%

P/E-6.92

P/B2.88

P/S—

P/FCF-7.98

EPS-4.24

Div yield—

ROE-41.61%

ROA-36.97%

Debt/Eq—

Current10.64

EV/EBITDA-5.11

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-20.24%

Price target84.20

Target upside169.44%

Analyst ratingBuy

Institutional89.82%

Ent. value512.87M

Revenue0

Net income-34.49M

Gross profit—

Free cash flow-78.36M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out15.8M

Employees131

ListedTue, Dec 19, 2023

Free float9.74M

Float %62.9%

Short interest3.14M

Days to cover13.6d

Short volume76.3%

Squeeze score100 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.53 vs −$1.40

Last surprise-9.3% miss

Setup gradeB

Conviction62 / 100

Pattern quality—

Tech rank60.2 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance41.22

Support32.52

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NGNE

All disclosures →

No recent disclosed trades by Congress in NGNE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NGNE · open-market 3 sells

Insider	Side	Shares	Value	Traded	Filed
Cvijic Christine Mikail President and CFO · Common Stock · 2026-07-07	Sell	4.2K	$152K	2026-07-07	2026-07-07
Cvijic Christine Mikail President and CFO · Common Stock · 2026-07-06	Sell	600	$22K	2026-07-06	2026-07-07
Cvijic Christine Mikail President and CFO · Common Stock · 2026-05-06	Sell	4.8K	$156K	2026-05-06	2026-05-08
Shafer Christina Chief Commercial Officer · Non-Qualified Stock Option (right to buy) · 2026-05-05	Grant	120K	$0	2026-05-05	2026-05-07

SEC filings

EDGAR filings in NGNE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.